GW Pharmaceuticals progress with diabetes, epilepsy and schizophrenia cannabis medicines
Clinical trials to use cannabis in the treatment of debilitating illness proving successful for licensed UK company. Whilst the release of their flagship medicine, Sativex and its success in 24